Lyufi-500 – antibacterial agent for system application. Levofloxacin.

Lyufi-500 it is shown for treatment at the adult such infections caused by microorganisms, sensitive to a levofloksatsin:

• sharp bacterial sinusitis;
• exacerbation of chronic bronchitis;
• not hospital pneumonia;
• complicated infections of leather and soft tissues.

in case of treatment of following infections when application of other bacterial means which are usually appointed for initial treatment of these infections is impossible:

• complicated infections of an urinary path (including pyelonephritises);
• chronic bacterial prostatitis;
• uncomplicated cystitis;
• inhalation anthrax: post-contact prevention and treatment.

Structure

• 1 tablet contains levofloxacin gemigidrat is equivalent to a levofloksatsin of 500 mg;
• other components: microcrystalline cellulose, krospovidon, the gipromeloz, the talc purified, stearylfumarating sodium, polyethyleneglycol, the titan dioxide (E 171), ferrous oxide yellow (E 172), ferrous oxide red (E 172).

Contraindication

Hypersensitivity to a levofloksatsin, other ftorkhinolona or to any component of medicine.

Epilepsy.

Injury of a sinew connected with preliminary application of ftorkhinolon.

Children's age.

Period of pregnancy and feeding by a breast.

Route of administration

Pill Lyufi-500 is taken by 1 or 2 times a day. The dose depends on type, weight of an infection and sensitivity of the expected activator.

Duration of treatment depends on the course of the disease and is no more than 14 days. It is recommended to continue treatment of Lyufi-500 of at least 48-72 hours after normalization of body temperature or the destruction of activators confirmed with microbiological tests.

Superinfection

At application of a levofloksatsin, especially long, development of opportunistic infections and growth of resistant microorganisms is possible

Feature of application. If against the background of therapy the superinfection develops, it is necessary to take the appropriate measures.

to

Pregnant

Drug is contraindicated to appointment to pregnant women.

to Children Lyufi-500 as injury of an articulate cartilage is not excluded is contraindicated to apply

.

Drivers

to the Patients running vehicles or working with other mechanisms, it is necessary to consider possible undesirable reactions from nervous system (dizziness / vertigo, drowsiness, confusion of consciousness, a visual disturbance and hearing, disorder of processes of the movement).

Overdose

Symptoms of overdose of Lyufi-500 are violations from the central nervous system (confusion of consciousness, dizziness, violation of consciousness and convulsive attacks); reactions from digestive system, such as nausea and erosion of mucous; lengthening of a QT interval is possible.

Side effects

Infection and invasion: fungal infections, including sort Candida mushrooms, proliferation of other resistant microorganisms, violation of normal intestinal microflora and development of consecutive infection.

from the system of blood and lymphatic system: a leukopenia, an eosinophilia, a neutropenia, the Agranulocytosis, a pancytopenia, hemolytic anemia, thrombocytopenia which can lead to increase in tendency to hemorrhages or bleedings.

from the immune system: reactions of hypersensitivity, including acute/anaphylactoid anaphylaxis which can be observed even within several minutes or hours after application of the first dose, a Quincke's disease, a small tortoiseshell, a spasm of bronchial tubes, suffocation, dropsy of cutaneous and mucous membranes, a sudden lowering of arterial pressure, shock.

to Store

in original packing at a temperature not over 25C in dry, protected from light and the place, inaccessible for children.